Role of Glycogen Synthase Kinase-3 in Insulin Resistance and Type 2 Diabetes

Publisher： Bentham Science Publishers

E-ISSN： 1873-5592|7|11|1435-1441

ISSN： 1389-4501

Source： Current Drug Targets, Vol.7, Iss.11, 2006-01, pp. : 1435-1441

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

The role of glycogen synthase kinase-3 in insulin resistance and Type 2 diabetes

By Eldar-Finkelman Hagit   Kaidanovich Oksana  

Expert Opinion on Therapeutic Targets, Vol. 6, Iss. 5, 2002-10 ,pp. : 555-561

Informa Healthcare

Access to resources Recommend Favorite

Challenges and opportunities with glycogen synthase kinase-3 inhibitors for insulin resistance and Type 2 diabetes treatment

By Eldar-Finkelman Hagit   Ilouz Ronit  

Expert Opinion on Investigational Drugs, Vol. 12, Iss. 9, 2003-09 ,pp. : 1511-1519

Informa Healthcare

Access to resources Recommend Favorite

Targeting glycogen synthase kinase-3 (GSK-3) in the treatment of Type 2 diabetes

By MacAulay Katrina   Woodgett James R  

Expert Opinion on Therapeutic Targets, Vol. 12, Iss. 10, 2008-10 ,pp. : 1265-1274

Informa Healthcare

Access to resources Recommend Favorite

Mechanisms linking diabetes mellitus to the development of atherosclerosis: a role for endoplasmic reticulum stress and glycogen synthase kinase-3

By Robertson Lindsie A.   Kim Anna J.   Werstuck Geoff H.  

Canadian Journal of Physiology and Pharmacology, Vol. 84, Iss. 1, 2006-01 ,pp. : 39-48

NRC Research Press

Access to resources Recommend Favorite

Vertex inhibitors of Aurora-2, glycogen synthase kinase-3 and Src kinase

By  

Expert Opinion on Therapeutic Patents, Vol. 14, Iss. 3, 2004-03 ,pp. : 439-443

Informa Healthcare

Access to resources Recommend Favorite